Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation.

Park JW, Cho JW, Joo SY, Kim CS, Choi JS, Bae EH, Ma SK, Kim SH, Lee J, Kim SW.

Eur J Pharmacol. 2012 May 15;683(1-3):301-9. doi: 10.1016/j.ejphar.2012.03.019. Epub 2012 Mar 16.

PMID:
22449373
2.

Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats.

Park JW, Bae EH, Kim IJ, Ma SK, Choi C, Lee J, Kim SW.

Am J Physiol Renal Physiol. 2010 Feb;298(2):F301-13. doi: 10.1152/ajprenal.00471.2009. Epub 2009 Nov 25. Erratum in: Am J Physiol Renal Physiol. 2010 Sep;299(3):F687-8.

3.

Paricalcitol attenuates cyclosporine-induced kidney injury in rats.

Park JW, Bae EH, Kim IJ, Ma SK, Choi C, Lee J, Kim SW.

Kidney Int. 2010 Jun;77(12):1076-85. doi: 10.1038/ki.2010.69. Epub 2010 Mar 17.

4.

Protective effect of paricalcitol on cyclosporine-induced renal injury in rats.

Piao SG, Song JC, Lim SW, Chung BH, Choi BS, Yang CW.

Transplant Proc. 2012 Apr;44(3):642-5. doi: 10.1016/j.transproceed.2011.12.004.

PMID:
22483459
5.

Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells.

Kim CS, Joo SY, Lee KE, Choi JS, Bae EH, Ma SK, Kim SH, Lee J, Kim SW.

PLoS One. 2013 May 17;8(5):e63186. doi: 10.1371/journal.pone.0063186. Print 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/ae0a1951-1b75-4a4f-865b-86acc4351139.

6.

Insulin-like growth factor-I increases p21 expression and attenuates cisplatin-induced acute renal injury in rats.

Yasuda H, Kato A, Miyaji T, Zhou H, Togawa A, Hishida A.

Clin Exp Nephrol. 2004 Mar;8(1):27-35.

PMID:
15067513
7.

Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.

Kim JH, Park DJ, Yun JC, Jung MH, Yeo HD, Kim HJ, Kim DW, Yang JI, Lee GW, Jeong SH, Roh GS, Chang SH.

Am J Physiol Renal Physiol. 2012 May 1;302(9):F1141-50. doi: 10.1152/ajprenal.00060.2011. Epub 2011 Dec 28.

8.

High glucose facilitates cell cycle arrest of rat bone marrow multipotent adult progenitor cells through transforming growth factor-β1 and extracellular signal-regulated kinase 1/2 signalling without changing Oct4 expression.

Luo M, Liu Z, Hao H, Lu T, Chen M, Lei M, Verfaillie CM, Liu Z.

Clin Exp Pharmacol Physiol. 2012 Oct;39(10):843-51. doi: 10.1111/j.1440-1681.2012.05747.x.

PMID:
22804759
9.

Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.

Qi S, Wu D.

Int J Mol Med. 2013 Dec;32(6):1262-72. doi: 10.3892/ijmm.2013.1517. Epub 2013 Oct 8.

10.

The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure.

Zhou H, Kato A, Yasuda H, Miyaji T, Fujigaki Y, Yamamoto T, Yonemura K, Hishida A.

Toxicol Appl Pharmacol. 2004 Oct 15;200(2):111-20.

PMID:
15476864
11.

Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines.

Chen CL, Chou KJ, Lee PT, Chen YS, Chang TY, Hsu CY, Huang WC, Chung HM, Fang HC.

Exp Cell Res. 2010 Apr 15;316(7):1109-18. doi: 10.1016/j.yexcr.2010.02.022. Epub 2010 Mar 2.

PMID:
20202468
12.

Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.

Alagbala AA, Johnson CS, Trump DL, Posner GH, Foster BA.

Oncology. 2006;70(6):483-92. Epub 2007 Jan 18.

PMID:
17237623
13.

Oral administration of oleuropein attenuates cisplatin-induced acute renal injury in mice through inhibition of ERK signaling.

Potočnjak I, Škoda M, Pernjak-Pugel E, Peršić MP, Domitrović R.

Mol Nutr Food Res. 2016 Mar;60(3):530-41. doi: 10.1002/mnfr.201500409. Epub 2015 Dec 18.

PMID:
26603374
14.

Renoprotective effect of paricalcitol via a modulation of the TLR4-NF-κB pathway in ischemia/reperfusion-induced acute kidney injury.

Lee JW, Kim SC, Ko YS, Lee HY, Cho E, Kim MG, Jo SK, Cho WY, Kim HK.

Biochem Biophys Res Commun. 2014 Feb 7;444(2):121-7. doi: 10.1016/j.bbrc.2014.01.005. Epub 2014 Jan 14.

PMID:
24434153
15.

Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.

Tan X, Li Y, Liu Y.

J Am Soc Nephrol. 2006 Dec;17(12):3382-93. Epub 2006 Nov 2.

16.

Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.

Jiang M, Wei Q, Wang J, Du Q, Yu J, Zhang L, Dong Z.

Oncogene. 2006 Jul 6;25(29):4056-66. Epub 2006 Feb 20.

PMID:
16491117
17.

Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats.

Kusumoto M, Kamobayashi H, Sato D, Komori M, Yoshimura M, Hamada A, Kohda Y, Tomita K, Saito H.

Clin Exp Nephrol. 2011 Dec;15(6):820-30. doi: 10.1007/s10157-011-0524-z. Epub 2011 Aug 23.

PMID:
21858734
18.

Renoprotective effects of the direct renin inhibitor aliskiren on gentamicin-induced nephrotoxicity in rats.

Bae EH, Kim IJ, Joo SY, Kim EY, Choi JS, Kim CS, Ma SK, Lee J, Kim SW.

J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):348-61. doi: 10.1177/1470320312474853. Epub 2013 Feb 18.

PMID:
23420778
19.

Ketoconazole potentiates the antitumor effects of nocodazole: In vivo therapy for human tumor xenografts in nude mice.

Wang YJ, Jeng JH, Chen RJ, Tseng H, Chen LC, Liang YC, Lin CH, Chen CH, Chu JS, Ho WL, Ho YS.

Mol Carcinog. 2002 Aug;34(4):199-210.

PMID:
12203371
20.

Molecular mechanisms underlying attenuation of cisplatin-induced acute kidney injury by epicatechin gallate.

Malik S, Suchal K, Bhatia J, Gamad N, Dinda AK, Gupta YK, Arya DS.

Lab Invest. 2016 Aug;96(8):853-61. doi: 10.1038/labinvest.2016.60. Epub 2016 May 30.

Supplemental Content

Support Center